Xcout Intel
ClearNote Health
ClearNote Health, Inc. is a pioneer in epigenomic technologies with corporate offices located in San Diego, California. The company has secured funding through SEC Form D filings to advance its biotechnology operations.
Subscribe to see ClearNote Health’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ClearNote Health at a glance
ClearNote Health is a biotech company headquartered in United States. Its most recent funding round raised $21.8M in May 2025. Xcout tracks 20 named people at ClearNote Health, including David Mullarkey (Chief Executive Officer). Xcout recorded 1 job posting from ClearNote Health in the last 90 days.
ClearNote Health leadership
- David MullarkeyChief Executive Officer
- Kevin KeeganChief Executive Officer
- Jeffrey M. VenstromChief Medical Officer
- Samuel LevyChief Scientific Officer
- Wayne VolkmuthSenior Vice President, Informatics & Data Discovery
- Anna BergamaschiVice President, Product R&D
14 more named people on record for ClearNote Health, with roles, board committees and tenure — see the full roster →
ClearNote Health funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $21.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at ClearNote Health
Xcout recorded 1 job posting from ClearNote Health in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see ClearNote Health's hiring signals →
ClearNote Health competitors
A few of ClearNote Health's closest competitors — see the full list of competitors and alternatives →
Adela, Inc. is an epigenomics-focused biotechnology company headquartered in Foster City, California. The company is advancing breakthrough approaches for the early detection of multiple types of cancer through blood tests.
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Hepta Bio, Inc. focuses on developing liquid biopsy technology for metabolic dysfunction-associated conditions, with headquarters in California.
Sarmal, Inc. is a San Diego-based biotechnology company founded in 2003 that develops next-generation genomic sequencing platforms, whole-genome sequencing technology, and field-deployable nucleic acid diagnostics. The company focuses on innovations in advanced nucleic acid sequencing and target sequence detection.
Genalyte is a biotechnology company headquartered in San Diego, California, that provides an on-site blood testing platform. The company's technology delivers real-time lab results directly to clinics in under 30 minutes.
Get ClearNote Health's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on ClearNote Health in Xcout Intel
- 20 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access